Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

BACKGROUND: Heterogeneity and lack of targeted therapies represent the two main impediments to precision treatment of triple-negative breast cancer (TNBC), and therefore, molecular subtyping and identification of therapeutic pathways are required to optimize medical care. The aim of the present stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Jézéquel, Pascal, Kerdraon, Olivier, Hondermarck, Hubert, Guérin-Charbonnel, Catherine, Lasla, Hamza, Gouraud, Wilfried, Canon, Jean-Luc, Gombos, Andrea, Dalenc, Florence, Delaloge, Suzette, Lemonnier, Jérôme, Loussouarn, Delphine, Verrièle, Véronique, Campone, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525459/
https://www.ncbi.nlm.nih.gov/pubmed/31101122
http://dx.doi.org/10.1186/s13058-019-1148-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525459/
https://www.ncbi.nlm.nih.gov/pubmed/31101122
http://dx.doi.org/10.1186/s13058-019-1148-6

Ejemplares similares